Carisma Therapeutics Inc. Public Float
Carisma Therapeutics Inc. had Public Float of $53.10 million as of 2024-06-28, per its 10-K/A filed 2025-04-29.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-04-29
- 2024-06-28: Entity Public Float $53.10M.
- 2023-06-30: Entity Public Float $275.73M.
- 2022-06-30: Entity Public Float $161.60M.
- 2021-06-30: Entity Public Float $870.70M.
| Period end | Entity Public Float |
|---|---|
| 2024-06-28 | $53.10M 10-K/A · filed 2025-04-29 |
| 2023-06-30 | $275.73M 10-K · filed 2024-04-01 |
| 2022-06-30 | $161.60M 10-K · filed 2023-02-28 |
| 2021-06-30 | $870.70M 10-K · filed 2022-02-28 |
| 2020-06-30 | $84.00M 10-K · filed 2021-03-15 |
| 2019-06-28 | $137.20M 10-K · filed 2020-03-16 |
| 2018-06-30 | $132.00M 10-K · filed 2019-03-01 |
| 2017-06-30 | $24.20M 10-K · filed 2018-04-02 |
| 2016-06-30 | $18.90M 10-K · filed 2017-03-24 |
| 2015-06-30 | $12.10M 10-K · filed 2016-03-25 |
| 2014-06-30 | $36.60M 10-K · filed 2015-03-06 |